Biol Reprod Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crankshaw, D. J.
Right arrow Articles by Ruzycky, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crankshaw, D. J.
Right arrow Articles by Ruzycky, A. L.
Agricola
Right arrow Articles by Crankshaw, D. J.
Right arrow Articles by Ruzycky, A. L.

Biology of Reproduction, Vol 30, 609-618, Copyright © 1984 by Society for the Study of Reproduction

ARTICLES

Characterization of putative beta-adrenoceptors in the myometrium of the pregnant ewe: correlation between the binding of [3H] dihydroalprenolol and the inhibition of myometrial contractility in vitro

DJ Crankshaw and AL Ruzycky

beta-Adrenoceptors in the myometrium of the pregnant ewe were studied both functionally and by radioligand binding techniques using [3H] dihydroalprenolol (DHA). Spontaneous contractile activity in vitro was inhibited by beta-adrenoceptor agonists in a stereoselective manner; the order of potency suggested a beta 2-adrenoceptor was involved. The effects of salbutamol were antagonized competitively by propranolol but the antagonism demonstrated by atenolol and ICI 118,551 (beta 1- and beta 2-selective, respectively) was complex. DHA binding was saturable, rapidly reversible, stereoselective and appeared to occur to a single class of noninteracting sites with a Kd of 4.1 +/- 0.3 nM and a maximal capacity of 0.8 +/- 0.05 pmol/mg protein. Agonists demonstrated the same order of potency in competition for ligand binding sites as in inhibition of contractile activity. These data suggested that the DHA binding sites were part of the beta-adrenoceptor. Strong agonists occupied only 0.1% of all receptors to produce the full response. Competition experiments with antagonists produced complex curves which could be resolved into two components comprising approximately 70% and 30% of the total number of sites. It was suggested that these sites represented beta 2- and beta 1-adrenoceptors, respectively. The possibility of regulation of the relative numbers of beta 2- and beta 1- adrenoceptors in the myometrium was discussed.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
C. Rouget, M. Bardou, M. Breuiller-Fouche, C. Loustalot, H. Qi, E. Naline, T. Croci, D. Cabrol, C. Advenier, and M. J. Leroy
{beta}3-Adrenoceptor Is the Predominant {beta}-Adrenoceptor Subtype in Human Myometrium and Its Expression Is Up-Regulated in Pregnancy
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1644 - 1650.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the Society for the Study of Reproduction.